Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt pathway.

Pan YR, Vatsyayan J, Chang YS, Chang HY.

Cell Microbiol. 2008 Dec;10(12):2447-60. doi: 10.1111/j.1462-5822.2008.01221.x. Epub 2008 Aug 19.

PMID:
18717819
2.
4.

PI3K/AKT, JNK, and ERK pathways are not crucial for the induction of cholesterol biosynthesis gene transcription in intestinal epithelial cells following treatment with the potato glycoalkaloid alpha-chaconine.

Mandimika T, Baykus H, Poortman J, Garza C, Kuiper H, Peijnenburg A.

J Agric Food Chem. 2008 Sep 24;56(18):8745-52. doi: 10.1021/jf800911m. Epub 2008 Aug 26.

PMID:
18729378
5.

RECK is a target of Epstein-Barr virus latent membrane protein 1.

Liu LT, Peng JP, Chang HC, Hung WC.

Oncogene. 2003 Nov 13;22(51):8263-70.

PMID:
14614450
6.

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.

Heussinger N, B├╝ttner M, Ott G, Brachtel E, Pilch BZ, Kremmer E, Niedobitek G.

J Pathol. 2004 Jun;203(2):696-9.

PMID:
15141385
7.

The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.

Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F, Matskova L, Ernberg I, Winberg G, Pawson T.

J Biol Chem. 2005 Oct 7;280(40):34133-42. Epub 2005 Aug 8.

8.

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

Ho CH, Chen CL, Li WY, Chen CJ.

Carcinogenesis. 2009 Aug;30(8):1443-51. doi: 10.1093/carcin/bgp135. Epub 2009 May 29.

PMID:
19483191
9.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

10.

Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.

Rechsteiner MP, Bernasconi M, Berger C, Nadal D.

Trends Microbiol. 2008 Nov;16(11):520-7. doi: 10.1016/j.tim.2008.08.007. Epub 2008 Oct 3.

PMID:
18835714
11.
12.

Expression and characterization of N-terminal domain of Epstein-Barr virus latent membrane protein 2A in Escherichia coli.

Park SJ, Seo MD, Lee SK, Ikeda M, Longnecker R, Lee BJ.

Protein Expr Purif. 2005 May;41(1):9-17.

PMID:
15802216
13.

Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation.

Schaadt E, Baier B, Mautner J, Bornkamm GW, Adler B.

J Gen Virol. 2005 Mar;86(Pt 3):551-9.

PMID:
15722514
14.

Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.

Scholle F, Longnecker R, Raab-Traub N.

Virology. 2001 Dec 20;291(2):208-14.

15.
16.

Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.

Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D.

J Virol. 2008 Feb;82(4):1739-47. Epub 2007 Dec 5.

17.

Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.

Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li LL, Luo W, Tang M, Cao Y.

Int J Mol Med. 2008 Feb;21(2):153-62.

PMID:
18204781
18.
19.
20.

WW domain-containing oxidoreductase is involved in upregulation of matrix metalloproteinase 9 by Epstein-Barr virus latent membrane protein 2A.

Lan YY, Wu SY, Lai HC, Chang NS, Chang FH, Tsai MH, Su IJ, Chang Y.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):672-6. doi: 10.1016/j.bbrc.2013.06.014. Epub 2013 Jun 11.

PMID:
23770367

Supplemental Content

Support Center